# Evaluation of the Safety and Immunogenicity of a Sublingual Influenza Vaccine NSV0001 in Healthy Male Volunteers

> **NCT02955030** · PHASE1 · COMPLETED · sponsor: **Nitto Denko Corporation** · enrollment: 90 (estimated)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** NSV0001
- **BIOLOGICAL:** Influenza HA vaccine "Biken HA"
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT02955030
- **Lead sponsor:** Nitto Denko Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2017-03
- **Final completion:** 2017-09
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2017-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02955030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02955030, "Evaluation of the Safety and Immunogenicity of a Sublingual Influenza Vaccine NSV0001 in Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02955030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*